Trgovina Onconova Therapeutics, Inc. - ONTX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.07 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 1.17 |
Odpri* | 1.17 |
Enoletna sprememba* | -11.36% |
Dnevni razpon* | 1.15 - 1.19 |
Razpon 52 wk | 0.62-1.52 |
Povprečni obseg (10 dni) | 77.75K |
Povprečni obseg (3 meseci) | 11.72M |
Tržna kapitalizacija | 25.16M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 20.97M |
Prihodki | 226.00K |
EPS | -0.99 |
Dividenda (donosnost v %) | N/A |
Beta | 1.78 |
Datum naslednjega zaslužka | Aug 9, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 7, 2023 | 1.16 | 0.00 | 0.00% | 1.16 | 1.19 | 1.15 |
Jun 6, 2023 | 1.17 | -0.05 | -4.10% | 1.22 | 1.23 | 1.16 |
Jun 5, 2023 | 1.19 | -0.01 | -0.83% | 1.20 | 1.22 | 1.19 |
Jun 2, 2023 | 1.16 | 0.00 | 0.00% | 1.16 | 1.20 | 1.15 |
Jun 1, 2023 | 1.16 | 0.04 | 3.57% | 1.12 | 1.18 | 1.10 |
May 31, 2023 | 1.11 | -0.02 | -1.77% | 1.13 | 1.14 | 1.09 |
May 30, 2023 | 1.11 | 0.05 | 4.72% | 1.06 | 1.15 | 1.06 |
May 26, 2023 | 1.07 | -0.07 | -6.14% | 1.14 | 1.17 | 1.06 |
May 25, 2023 | 1.15 | -0.09 | -7.26% | 1.24 | 1.28 | 1.13 |
May 24, 2023 | 1.21 | -0.03 | -2.42% | 1.24 | 1.24 | 1.19 |
May 23, 2023 | 1.20 | 0.05 | 4.35% | 1.15 | 1.27 | 1.15 |
May 22, 2023 | 1.15 | -0.01 | -0.86% | 1.16 | 1.16 | 1.11 |
May 19, 2023 | 1.14 | -0.02 | -1.72% | 1.16 | 1.19 | 1.11 |
May 18, 2023 | 1.15 | 0.04 | 3.60% | 1.11 | 1.16 | 1.10 |
May 17, 2023 | 1.10 | 0.00 | 0.00% | 1.10 | 1.14 | 1.08 |
May 16, 2023 | 1.11 | -0.02 | -1.77% | 1.13 | 1.18 | 1.11 |
May 15, 2023 | 1.15 | -0.08 | -6.50% | 1.23 | 1.23 | 1.13 |
May 12, 2023 | 1.23 | 0.09 | 7.89% | 1.14 | 1.28 | 1.14 |
May 11, 2023 | 1.17 | -0.10 | -7.87% | 1.27 | 1.29 | 1.15 |
May 10, 2023 | 1.27 | -0.04 | -3.05% | 1.31 | 1.34 | 1.25 |
Onconova Therapeutics, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Wednesday, August 9, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q2 2023 Onconova Therapeutics Inc Earnings Release Q2 2023 Onconova Therapeutics Inc Earnings ReleaseForecast -Previous - |
Friday, August 18, 2023 | ||
Čas (UTC) (UTC) 14:00 | Država US
| Dogodek Onconova Therapeutics Inc Annual Shareholders Meeting Onconova Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
Monday, November 13, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q3 2023 Onconova Therapeutics Inc Earnings Release Q3 2023 Onconova Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0.226 | 0.226 | 0.231 | 2.183 | 1.228 |
Prihodki | 0.226 | 0.226 | 0.231 | 2.183 | 1.228 |
Celotni odhodki iz poslovanja | 19.853 | 16.722 | 25.224 | 23.882 | 24.51 |
Celotna prodaja/splošni/upravni stroški Odhodki | 8.447 | 9.425 | 8.326 | 8.345 | 7.586 |
Raziskave in razvoj | 11.406 | 7.297 | 16.898 | 15.537 | 16.924 |
Prihodki iz poslovanja | -19.627 | -16.496 | -24.993 | -21.699 | -23.282 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0 | 0.321 | -0.208 | 0.063 | 1.597 |
Drugo, neto | 0.663 | 0.012 | 0.048 | 0.143 | 1.151 |
Čisti dobiček pred obdavčitvijo | -18.964 | -16.163 | -25.153 | -21.493 | -20.534 |
Čisti dobiček po davkih | -18.964 | -16.163 | -25.157 | -21.503 | -20.41 |
Manjšinski delež | -0.163 | ||||
Čisti dobiček pred dodatnimi postavkami | -18.964 | -16.163 | -25.157 | -21.503 | -20.573 |
Čisti dobiček | -18.964 | -16.163 | -25.157 | -21.503 | -20.573 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -18.964 | -16.163 | -25.157 | -21.503 | -20.573 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -18.964 | -16.163 | -25.157 | -21.503 | -20.573 |
Popravljen čisti dobiček | -18.964 | -16.163 | -25.157 | -21.503 | -20.573 |
Popravljene ponderirane povprečne delnice | 20.9082 | 16.8322 | 11.603 | 0.95901 | 0.27495 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.90701 | -0.96024 | -2.16815 | -22.422 | -74.824 |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.90701 | -0.96024 | -2.16815 | -22.422 | -74.824 |
Skupaj izredne postavke |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0.056 | 0.056 | 0.057 | 0.057 | 0.056 |
Prihodki | 0.056 | 0.056 | 0.057 | 0.057 | 0.056 |
Celotni odhodki iz poslovanja | 6.193 | 5.79 | 5.698 | 4.177 | 4.188 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2.113 | 2.017 | 2.105 | 2.139 | 2.186 |
Raziskave in razvoj | 4.08 | 3.773 | 3.593 | 2.038 | 2.002 |
Prihodki iz poslovanja | -6.137 | -5.734 | -5.641 | -4.12 | -4.132 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0 | 0 | 0 | 0 | |
Drugo, neto | 0.362 | 0.314 | 0.243 | 0.096 | 0.01 |
Čisti dobiček pred obdavčitvijo | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Čisti dobiček po davkih | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Čisti dobiček pred dodatnimi postavkami | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Čisti dobiček | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Popravljen čisti dobiček | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 |
Popravljene ponderirane povprečne delnice | 20.9602 | 20.9262 | 20.9154 | 20.9041 | 20.9041 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.27552 | -0.25901 | -0.25809 | -0.1925 | -0.19719 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.27552 | -0.25901 | -0.25809 | -0.1925 | -0.19719 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 39.347 | 55.43 | 19.784 | 23.474 | 17.765 |
Denarna sredstva in kratkoročne naložbe | 38.757 | 55.07 | 19.025 | 22.726 | 16.97 |
Denarna sredstva in ustrezniki | 38.757 | 55.07 | 19.025 | 22.726 | 16.97 |
Celotne terjatve, neto | 0.029 | 0.028 | 0.037 | 0.098 | 0.035 |
Accounts Receivable - Trade, Net | 0.029 | 0.028 | 0.037 | 0.098 | 0.035 |
Prepaid Expenses | 0.521 | 0.297 | 0.542 | 0.51 | 0.76 |
Other Current Assets, Total | 0.04 | 0.035 | 0.18 | 0.14 | |
Total Assets | 39.372 | 55.478 | 19.986 | 23.674 | 17.923 |
Property/Plant/Equipment, Total - Net | 0.024 | 0.038 | 0.052 | 0.05 | 0.009 |
Property/Plant/Equipment, Total - Gross | 0.07 | 0.07 | 0.07 | ||
Accumulated Depreciation, Total | -0.046 | -0.032 | -0.018 | ||
Other Long Term Assets, Total | 0.001 | 0.01 | 0.15 | 0.15 | 0.149 |
Total Current Liabilities | 8.046 | 6.115 | 10.021 | 8.292 | 8.438 |
Accounts Payable | 3.86 | 2.757 | 4.833 | 0.476 | 4.039 |
Accrued Expenses | 3.78 | 2.976 | 4.78 | 7.348 | 4.173 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.406 | 0.382 | 0.408 | 0.468 | 0.226 |
Total Liabilities | 11.063 | 9.358 | 13.811 | 12.1 | 12.536 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | |||
Other Liabilities, Total | 3.017 | 3.243 | 3.79 | 3.808 | 4.098 |
Total Equity | 28.309 | 46.12 | 6.175 | 11.574 | 5.387 |
Redeemable Preferred Stock | |||||
Common Stock | 0.209 | 0.209 | 1.859 | 1.112 | 0.057 |
Additional Paid-In Capital | 491.816 | 490.644 | 432.858 | 413.879 | 387.238 |
Retained Earnings (Accumulated Deficit) | -463.683 | -444.719 | -428.556 | -403.399 | -381.896 |
Other Equity, Total | -0.033 | -0.014 | 0.014 | -0.018 | -0.012 |
Total Liabilities & Shareholders’ Equity | 39.372 | 55.478 | 19.986 | 23.674 | 17.923 |
Total Common Shares Outstanding | 20.926 | 20.8956 | 12.3968 | 7.41153 | 0.3783 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 35.039 | 39.347 | 43.751 | 48.033 | 51.377 |
Denarna sredstva in kratkoročne naložbe | 34.22 | 38.757 | 42.613 | 46.533 | 50.767 |
Denarna sredstva in ustrezniki | 34.22 | 38.757 | 42.613 | 46.533 | 50.767 |
Celotne terjatve, neto | 0.017 | 0.029 | 0.028 | 0.028 | 0.027 |
Accounts Receivable - Trade, Net | 0.017 | 0.029 | 0.028 | 0.028 | 0.027 |
Prepaid Expenses | 0.734 | 0.521 | 0.807 | 1.166 | 0.277 |
Other Current Assets, Total | 0.068 | 0.04 | 0.303 | 0.306 | 0.306 |
Total Assets | 35.061 | 39.372 | 43.78 | 48.074 | 51.422 |
Property/Plant/Equipment, Total - Net | 0.021 | 0.024 | 0.028 | 0.031 | 0.035 |
Property/Plant/Equipment, Total - Gross | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Accumulated Depreciation, Total | -0.049 | -0.046 | -0.042 | -0.039 | -0.035 |
Other Long Term Assets, Total | 0.001 | 0.001 | 0.001 | 0.01 | 0.01 |
Total Current Liabilities | 9.224 | 8.046 | 7.336 | 6.46 | 5.948 |
Accounts Payable | 4.896 | 3.86 | 3.76 | 3.003 | 3.122 |
Accrued Expenses | 3.984 | 3.78 | 3.131 | 3.022 | 2.492 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.344 | 0.406 | 0.445 | 0.435 | 0.334 |
Total Liabilities | 12.185 | 11.063 | 10.409 | 9.59 | 9.135 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 2.961 | 3.017 | 3.073 | 3.13 | 3.187 |
Total Equity | 22.876 | 28.309 | 33.371 | 38.484 | 42.287 |
Common Stock | 0.21 | 0.209 | 0.209 | 0.209 | 0.209 |
Additional Paid-In Capital | 492.151 | 491.816 | 491.486 | 491.181 | 490.94 |
Retained Earnings (Accumulated Deficit) | -469.458 | -463.683 | -458.263 | -452.865 | -448.841 |
Other Equity, Total | -0.027 | -0.033 | -0.061 | -0.041 | -0.021 |
Total Liabilities & Shareholders’ Equity | 35.061 | 39.372 | 43.78 | 48.074 | 51.422 |
Total Common Shares Outstanding | 20.9696 | 20.926 | 20.926 | 20.8956 | 20.8956 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -18.964 | -16.163 | -25.157 | -21.503 | -20.41 |
Denarna sredstva iz poslovanja | -16.294 | -19.487 | -23.075 | -20.831 | -22.696 |
Denarna sredstva iz poslovanja | 0.014 | 0.014 | 0.013 | 0.014 | 0.055 |
Nedenarne postavke | 1.172 | 0.255 | 0.577 | 0.985 | -1.274 |
Spremembe v obratnem kapitalu | 1.484 | -3.593 | 1.492 | -0.327 | -1.067 |
Denarna sredstva pri naložbenju | 0 | -0.015 | -0.055 | 0 | |
Celotne druge postavke denarnih tokov pri naložbenju | 0 | ||||
Denarna sredstva pri financiranju | 0 | 55.56 | 19.357 | 26.648 | 35.657 |
Izdaja (odplačilo) delnic, neto | 0 | 55.56 | 19.357 | 26.648 | 35.657 |
Učinki deviznih tečajev | -0.019 | -0.028 | 0.032 | -0.006 | -0.015 |
Neto sprememba denarnih sredstev | -16.313 | 36.045 | -3.701 | 5.756 | 12.946 |
Kapitalski izdatki | 0 | -0.015 | -0.055 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -5.775 | -18.964 | -13.544 | -8.146 | -4.122 |
Cash From Operating Activities | -4.543 | -16.294 | -12.41 | -8.51 | -4.296 |
Cash From Operating Activities | 0.003 | 0.014 | 0.01 | 0.007 | 0.003 |
Non-Cash Items | 0.336 | 1.172 | 0.842 | 0.537 | 0.296 |
Changes in Working Capital | 0.893 | 1.484 | 0.282 | -0.908 | -0.473 |
Cash From Financing Activities | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
Foreign Exchange Effects | 0.006 | -0.019 | -0.047 | -0.027 | -0.007 |
Net Change in Cash | -4.537 | -16.313 | -12.457 | -8.537 | -4.303 |
Cash From Investing Activities | |||||
Capital Expenditures |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.9724 | 623304 | 0 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.1869 | 248881 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8083 | 169501 | 0 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.6905 | 144794 | -22852 | 2023-03-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2517 | 52790 | 0 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.224 | 46968 | -34853 | 2023-03-31 | HIGH |
Fruchtman (Steven M) | Individual Investor | 0.193 | 40477 | 0 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1468 | 30783 | 0 | 2023-03-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.1354 | 28395 | 28395 | 2023-03-31 | HIGH |
Marino (James J) | Individual Investor | 0.1017 | 21334 | 0 | 2023-03-31 | LOW |
Guerin Mark Patrick | Individual Investor | 0.0867 | 18191 | 0 | 2023-03-31 | LOW |
Hillcrest Wealth Advisors - NY, LLC | Investment Advisor | 0.0797 | 16723 | 0 | 2023-03-31 | LOW |
Mehta (Viren) | Individual Investor | 0.0797 | 16722 | 0 | 2023-03-31 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.0696 | 14595 | 124 | 2023-03-31 | LOW |
Beacon Pointe Advisors LLC | Investment Advisor | 0.0626 | 13131 | -26207 | 2023-03-31 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 0.0503 | 10552 | 0 | 2023-03-31 | MED |
Gelder (Mark S) | Individual Investor | 0.05 | 10487 | 0 | 2023-03-31 | LOW |
Jane Street Capital, L.L.C. | Research Firm | 0.0492 | 10308 | -4848 | 2023-03-31 | HIGH |
Edmond de Rothschild Asset Management (France) S.A. | Investment Advisor | 0.0318 | 6666 | 0 | 2023-03-31 | LOW |
Tower Research Capital LLC | Hedge Fund | 0.025 | 5245 | 5245 | 2023-03-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Onconova Therapeutics, Inc. Company profile
O družbi Onconova Therapeutics, Inc.
Onconova Therapeutics, Inc. je biofarmacevtsko podjetje v klinični fazi. Podjetje se osredotoča na odkrivanje in razvoj izdelkov za bolnike z rakom. Družba je ustvarila usmerjeno sredstvo proti raku, ki je zasnovano tako, da moti določene celične poti, ki so pomembne za razmnoževanje rakavih celic. Njena priprava vključuje dva programa v klinični fazi. Kandidat za izdelek ON 123300 je večkinazni zaviralec, usmerjen v ciklinsko odvisno kinazo (CDK 4/6) in druge tirozinske kinaze, ki spodbujajo proliferacijo tumorjev. Njegov drugi kandidat za izdelek Oral Rigosertib v kombinaciji z zaviralcem PD-1 je namenjen bolnikom z nedrobnoceličnim pljučnim rakom (NSCLC) z mutacijo K-Ras.
Industry: | Biopharmaceuticals |
375 Pheasant Run
NEWTOWN
PENNSYLVANIA 18940
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com